论文部分内容阅读
2000年8月至2001年6月应用百奥蚓激酶治疗脑梗塞30例,与对照组比较,疗效较好,总结报告如下。 1 资料与方法 1.1 病例选择 所选60例脑梗塞患者均符合脑梗塞形成的病史、症状、体征,并经头颅CT证实有脑梗塞病灶。将患者随机分为治疗组和对照组,其中治疗组男性18例,女性12例,年龄61～78岁,平均63.2岁;病程最短1天,最长40天,平均16天;既往有高血压病22例,冠心病10例,糖尿病1例;脑叶梗塞
August 2000 to June 2001 application of lumbrokinase in the treatment of 30 cases of cerebral infarction, compared with the control group, the effect is better, the summary report is as follows. 1 Materials and Methods 1.1 Case Selection The selected 60 patients with cerebral infarction are in line with the history of cerebral infarction, symptoms, signs, and cerebral infarction confirmed by head CT lesions. The patients were randomly divided into treatment group and control group. The treatment group, 18 males and 12 females, aged from 61 to 78 years (average 63.2 years); the shortest course of one day, the longest 40 days, an average of 16 days; previous high blood pressure 22 cases of disease, coronary heart disease in 10 cases, 1 case of diabetes; cerebral infarction